How do you manage risks and uncertainties in signal detection, strengthening and refinement or determine the lag between start of exposure to a drug and the onset of an AE? SÆfetyWorks' analytical modules can help. Check out our latest video to learn more.
Large, diverse U.S. and European healthcare data sources are increasingly popular, enabling an evidence-based approach to research, development, drug safety, and commercial strategy. However, healthcare data sources are inconsistent in content and format, making them difficult to analyze in a manner that is timely, cost-efficient, and valuable.